Overexpression of protein kinase C-α and -β isozymes by stromal dendritic cells in basal and squamous cell carcinoma

British Journal of Dermatology

Volumn 136, Issue 5, 1997, Pages 666-673

  Reynolds, N J ^a,b   Todd, C ^a   Angus, B ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; ISOENZYME; PROTEIN KINASE C; STROMELYSIN;

ARTICLE; BASAL CELL CARCINOMA; CANCER INVASION; CARCINOGENESIS; CLINICAL ARTICLE; DENDRITIC CELL; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STROMA CELL;

EID: 0031008573     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb03649.x     Document Type: Article

References (43)

1. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 1988: 334: 661-5.
2. Hawley-Nelson P, Stanley JR, Schmidt J et al. The tumor promoter. 12-O-tetradecanoylphorbol-13-acetate accelerates keratinocyte differentiation and stimulates growth of an unidentified cell type in cultured human epidermis. Exp Cell Res 1982: 137: 155-67.
3. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1942: 258: 607-14.
4. Osada S, Mizuno K, Saido TC et al. A new member of the protein kinase C family, nPKC theta, predominantly expressed in skeletal muscle. Mol Cell Biol 1992: 12: 3930-8.
5. Selbie LA, Schmitz-Peiffer C, Sheng Y, Biden TJ. Molecular cloning and characterization of PKC-iota, an atypical isoform of protein kinase C derived from insulin-secreting cells. J Biol Chem 1993: 32: 24296-302.
6. Johannes FJ, Prestle J, Eis S et al. PKCu is a novel, atypical member of the protein kinase C family. J Biol Chem 1994: 269: 6140-8.
7. Weisel WC, Khan WA, Merchenthaler I et al. Tissue and cellular distribution of the extended family of protein kinase C isoenzymes. J Cell Biol 1992: 117: 121-33.
8. Fisher GJ, Tavakkol A, Leach K et al. Differential expression of protein kinase C isoenzymes in normal and psoriatic adult human skin. J Invest Dermatol 1993: 101: 553-9.
9. Reynolds NJ, Baldassare JJ, Henderson PA et al. Translocation and downregulation of protein kinase C isoenzymes-alpha and -epsilon by phorbol ester and bryostatin-1 in human keratinocytes and fibroblasts. J Invest Dermatol 1994; 103: 364-9.
10. Housey GM, Johnson MD, Hsiao WL et al. Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell 1988: 52: 343-54.
11. Mischak H, Goodnight JA, Kolch W et al. Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Mol Chem 1993: 268: 6090-6.
12. Cacace AM, Guadagno SN, Krauss RS et al. The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene 1993: 8: 2095-104.
13. Perletti GP, Folini M, Lin H et al. Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells. Oncogen 1996: 12: 847-54.
14. Smart RC, Mills KJ, Hansen LA, Conney AH. Synthetic lipid second messenger sn-1,2-didecanoylglycerol: a complete tumor promoter in mouse skin. Cancer Res 1989: 49: 4455-8.
15. Mills KJ, Bocckino SB, Burns DJ et al. Alterations in protein kinase C isozymes alpha and beta 2 in activated Ha-ras containing papillomas in the absence of an increase in diacylglycerol. Carcinogenesis 1992: 13: 1113-20.
16. Shimizu T, Usuda N, Sugenoya A et al. Immunohistochemical evidence for the overexpression of protein kinase C in proliferative diseases of human thyroid. Cell Mol Biol 1991: 37: 813-21.
17. Alvaro V, Levy L, Dubray C et al. Invasive human pituitary tumors express a point-mutated alpha-protein kinase-C. J Clin Endocrinol Metab 1993: 77: 1125-9.
18. Guillem JG, O'Brian CA, Fitzer CJ et al. Altered levels of protein kinase C and Ca2+-dependent protein kinases in human colon carcinomas. Cancer Res 1987: 47: 2036-9.
19. Kopp R, Noelke B, Sauter G et al. Altered protein kinase C activity in biopsies of human colonic adenomas and carcinomas. Cancer Res 1991: 51: 205-10.
20. Koizumi H, Kohno Y, Osada S et al. Differentiation-associated localization of nPKC eta, a Ca(++)-independent protein kinase C, in normal human skin and skin diseases. J Invest Dermatol 1993: 101: 858-63.
21. Quinn AG, Sikkink S, Rees JL. Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss. Cancer Res 1994: 54: 4756-9.
22. Johnson RL, Rothman AL, Xie J et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996: 272: 1668-71.
23. Hahn H, Wieking C, Zaphiropoulos PG et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996: 85: 841-51.
24. Rehman I, Quinn AG, Healy E, Rees JL. High frequency of loss of heterozygosity in actinic keratoses, a usually benign disease. Lancet 1994: 344: 788-9.
25. Hidaka H, Tanaka T, Onoda K et al. Cell type-specific expression of protein kinase C isozymes in the rabbit cerebellum. J Biol Chem 1988: 263: 4523-6.
26. Baldassare JJ, Henderson PA, Burns D et al. Translocation of protein kinase C isozymes in thrombin-stimulated human platelets. J Biol Chem 1992: 267: 15585-90.
27. Cerio R, Griffiths CE, Cooper KD et al. Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol 1989: 121: 421-31.
28. Allen MH, Markey AC, MacDonald DM. The development of a reproducible immunocytochemical technique for demonstrating colocalized cutaneous antigens. Am J Dermatopathol 1991: 13: 221-7.
29. Reynolds NJ, Yi JY, Fisher GJ et al. Down-regulation of Langerhans cell protein kinase C-beta isoenzyme expression in inflammatory and hyperplastic dermatoses. Br J Dermatol 1995: 133: 157-67.
30. Todo T, Shitara N, Nakamura H et al. Astrocytic localization of the immunoreactivity for protein kinase C isozyme (type III) in human brain. Brain Res 1990: 517: 351-3.
31. Clark EA, Leach KL, Trojanowski JQ, Lee VM. Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains. Lab Invest 1991: 64: 35-44.
32. Nestle FO, Nickoloff BJ. A fresh morphological and functional look at dermal dendritic cells. J Cutan Pathol 1995: 22: 385-93.
33. Van Scott EJ, Reinertson RP. The modulating influence of stromal environment on epithelial cells studied in human autotransplants. J Invest Dermatol 1961: 36: 109-17.
34. Pyke C, Ralfkiaer E, Huhtala P et al. Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res 1992: 52: 1336-41.
35. Majmudar G, Nelson BR, Jensen TC et al. Increased expression of stromelysin-3 in basal cell carcinomas. Mol Carcinog 1994: 9: 17-23.
36. Nestle FO, Zheng XC, Thompson CB et al. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol 1993: 151: 6535-45.
37. Headington JT, Cerio R. Dendritic cells and the dermis. Am J Dermatopathol 1990: 12: 217-20.
38. Kradin RL, Lynch GW, Kurnick JT et al. Factor XIII A is synthesized and expressed on the surface of U937 cells and alveolar macrophages. Blood 1987: 69: 778-85.
39. Adany R, Glukhova MA, Kabakov AY, Muszbek L. Characterisation of connective tissue cells containing factor XIII subunit a. J Clin Pathol 1988: 41: 49-56.
40. Penneys NS. Factor XIII expression in the skin: observations and a hypothesis. J Am Acad Dermatol 1990: 22: 484-8.
41. Toida M, Okumura Y, Takami T. Cells containing factor XIIIa and pulmonary fibrosis induced by bleomycin. J Clin Pathol 1991: 44: 255-5.
42. Mosher DF, Schad PE, Vann JM. Cross-linking of collagen and fibronectin by factor XIIIa. Localization of participating glutaminyl residues to a tryptic fragment of fibronectin. J Biol Chem 1980: 255: 1181-8.
43. Prevostel C, Alvaro V, de Boisvilliers F et al. The natural protein kinase-alpha mutant in thyroid neoplasms. Oncogene 1995: 11: 669-74.